ATE279404T1 - Hydrate und kristalle einer neuraminsäureverbindung - Google Patents

Hydrate und kristalle einer neuraminsäureverbindung

Info

Publication number
ATE279404T1
ATE279404T1 AT01925919T AT01925919T ATE279404T1 AT E279404 T1 ATE279404 T1 AT E279404T1 AT 01925919 T AT01925919 T AT 01925919T AT 01925919 T AT01925919 T AT 01925919T AT E279404 T1 ATE279404 T1 AT E279404T1
Authority
AT
Austria
Prior art keywords
hydrates
crystals
acid compound
neuramic acid
neuramic
Prior art date
Application number
AT01925919T
Other languages
English (en)
Inventor
Masayuki Murakami
Masashi Watanabe
Takeshi Honda
Makoto Yamaoka
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Application granted granted Critical
Publication of ATE279404T1 publication Critical patent/ATE279404T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyrane Compounds (AREA)
AT01925919T 2000-04-25 2001-04-25 Hydrate und kristalle einer neuraminsäureverbindung ATE279404T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000123807 2000-04-25
PCT/JP2001/003583 WO2001081331A1 (en) 2000-04-25 2001-04-25 Hydrates and crystals of a neuraminic acid compound

Publications (1)

Publication Number Publication Date
ATE279404T1 true ATE279404T1 (de) 2004-10-15

Family

ID=18634042

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01925919T ATE279404T1 (de) 2000-04-25 2001-04-25 Hydrate und kristalle einer neuraminsäureverbindung

Country Status (12)

Country Link
US (1) US6844363B2 (de)
EP (1) EP1277750B1 (de)
AT (1) ATE279404T1 (de)
AU (2) AU5257901A (de)
CA (1) CA2407468C (de)
DE (1) DE60106421T2 (de)
ES (1) ES2228848T3 (de)
HK (1) HK1049335B (de)
PT (1) PT1277750E (de)
TR (1) TR200402776T4 (de)
TW (1) TWI291462B (de)
WO (1) WO2001081331A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20011350A1 (es) 2000-05-19 2002-01-15 Vertex Pharma PROFARMACO DE UN INHIBIDOR DE ENZIMA CONVERTIDORA DE INTERLEUCINA-1ß (ICE)
WO2002092555A1 (en) * 2001-05-11 2002-11-21 Sankyo Company, Limited Sialic acid derivatives
KR101135765B1 (ko) * 2004-03-12 2012-04-23 버텍스 파마슈티칼스 인코포레이티드 아스파르트산 아세탈 카스파아제 억제제의 제조를 위한방법 및 중간체
US7776869B2 (en) 2004-10-18 2010-08-17 Amgen Inc. Heteroaryl-substituted alkyne compounds and method of use
CN100471848C (zh) * 2006-06-05 2009-03-25 中国医学科学院医药生物技术研究所 一组长链烷氧烷基取代唾液酸衍生物及其制备方法
JP5286251B2 (ja) * 2007-03-07 2013-09-11 第一三共株式会社 インフルエンザ治療剤
TWI460182B (zh) 2007-04-11 2014-11-11 Daiichi Sankyo Co Ltd 原酸酯之製造方法
TWI491416B (zh) 2008-12-24 2015-07-11 Daiichi Sankyo Co Ltd 吸入用乾燥粉末醫藥組成物
CN101787008A (zh) * 2009-01-23 2010-07-28 中国科学院上海药物研究所 N-乙酰神经氨酸类化合物、其药物组合物及其制备方法和用途
ES2640001T3 (es) 2011-12-16 2017-10-31 Daiichi Sankyo Company, Limited Procedimiento de producción de un derivado del ácido neuramínico
EP4074414A1 (de) * 2021-04-15 2022-10-19 Molecule RND Limited Kristalline sorbensmaterialien zur aufnahme und freisetzung von wasser

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2745059B2 (ja) * 1989-03-08 1998-04-28 メクト株式会社 Ｎ―アセチルノイラミン酸ナトリウム・三水和物
GB9325841D0 (en) * 1993-12-17 1994-02-23 Glaxo Group Ltd Chemical compounds
ATE211468T1 (de) * 1996-07-22 2002-01-15 Sankyo Co Neuraminsäuredervate, ihre herstellung und medizinische verwendung
US6340702B1 (en) * 1996-07-22 2002-01-22 Sankyo Company, Limited Neuraminic acid derivatives, their preparation and their medical use

Also Published As

Publication number Publication date
HK1049335B (en) 2005-03-11
ES2228848T3 (es) 2005-04-16
DE60106421D1 (de) 2004-11-18
TR200402776T4 (tr) 2004-12-21
AU2001252579B2 (en) 2004-09-30
DE60106421T2 (de) 2005-06-30
CA2407468A1 (en) 2002-10-23
CA2407468C (en) 2009-06-30
PT1277750E (pt) 2004-12-31
EP1277750B1 (de) 2004-10-13
TWI291462B (en) 2007-12-21
AU5257901A (en) 2001-11-07
EP1277750A1 (de) 2003-01-22
US6844363B2 (en) 2005-01-18
WO2001081331A1 (en) 2001-11-01
HK1049335A1 (en) 2003-05-09
US20030105158A1 (en) 2003-06-05
EP1277750A4 (de) 2003-05-28

Similar Documents

Publication Publication Date Title
MY128773A (en) Substituted phenyl derivatives
CA2296604A1 (en) Crystal modification of a n-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
SE9802974D0 (sv) New crystalline forms
DE60032780D1 (de) Tetrahydroquinolin-derivate
PL367259A1 (en) Piperidine derivatives as nmda receptor antagonists
DK0931788T3 (da) Metalloproteasehæmmere
ATE368655T1 (de) Stickstoffhaltige heterocyclische verbindung und arzneimittel davon
DE60124504D1 (de) Stabile emulsionszubereitungen
SI1392642T1 (sl) Nove spojine kot protivnetna, imunomodulacijska in antiproliferativna sredstva
EA200602170A1 (ru) Производные пиперидина, композиции на их основе, способы их применения
EP1490371A4 (de) Tricyclische verbindungen auf thiophengrundlage und pharmazeutische zusammensetzungen, die diese enthalten
DE60106421D1 (de) Hydrate und kristalle einer neuraminsäureverbindung
WO2003028728A8 (en) 4-(4-substituted piperazinyl-1yl)-butylcarboxamides as d3 dopamine subtype selective ligands
EP1020452A4 (de) Benzimidazolderivate
ATE40684T1 (de) (benzoyl-4-piperidino)-2-phenyl-1alkanolderivate, ihre herstellung und ihre verwendung als heilmittel.
BR9913405A (pt) Composto heterocìclico que contenha oxigênio, e, inibidor de fosfodiesterase (pde) iv.
DK1447400T3 (da) Bicyklisk forbindelse
DE60015390D1 (de) Antidiabetische thiazolidindione und ihre herstellung
DK1270575T3 (da) Hidtil ukendt krystallinsk form af et pyrrolidylthiocarbapenemderivat
ATE360612T1 (de) In 4-stellung substituierte piperidinderivate
UA86031C2 (ru) Применение скопинового эфира как исходного материала для получения соединений, которые проявляют терапевтическое действие
DK1325923T3 (da) Cephem-forbindelser og ESBL-detekterende reagenser indeholdende disse
SE9902550D0 (sv) New crystalline forms
CA2149239A1 (en) Herbicidal sulfonylureas, their preparation and use
CO5150201A1 (es) Derivados de piperidina

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1277750

Country of ref document: EP

EEIH Change in the person of patent owner